Why Urban Outfitters Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

Author: Avi Kapoor | May 22, 2024 08:16am

Shares of Urban Outfitters, Inc. (NASDAQ:URBN) rose sharply in today's pre-market trading after the company reported better-than-expected financial results for its first quarter on Tuesday.

The company reported quarterly earnings of 69 cents per share, which beat the analyst consensus estimate of 52 cents. Quarterly sales clocked in at $1.2 billion, beating the analyst consensus estimate of $1.175 billion, according to data from Benzinga Pro.

Urban Outfitters shares jumped 6.7% to $44.10 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

MGO Global, Inc. (NASDAQ:MGOL) gained 91.2% to $2.39 in pre-market trading. MGO Global shares jumped around 447% on Tuesday after the company posted a year-over-year increase in its first-quarter financial results.
Barnes & Noble Education, Inc. (NYSE:BNED) rose 66.8% to $0.9009 in today's pre-market trading. Barnes & Noble shares jumped 74% on Tuesday, potentially driven by ongoing developments surrounding a potential strategic transaction with the company.
Mustang Bio, Inc. (NASDAQ:MBIO) shares gained 64.5% to $0.5098 in pre-market trading after falling over 8% on Tuesday.
Akoustis Technologies, Inc. (NASDAQ:AKTS) gained 51.8% to $0.2091 in pre-market trading after falling around 13% on Tuesday. Akoustis Technologies recently announced that a jury in the U.S. District Court for the District of Delaware ruled in favor of Qorvo Inc. in a lawsuit against Akoustis.
Rezolute, Inc. (NASDAQ:RZLT) shares rose 46% to $4.38 in pre-market trading after the company reported topline results from its Phase 2 clinical study of RZ402 in patients with DME met primary study endpoints.
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) shares gained 32.5% to $3.83 in pre-market trading after the company announced data from its Phase 1b/2a RESOLVE trial showing ‘tolerability and extended signals of potential efficacy out to 24 weeks without meaningful side effects.’
Mangoceuticals, Inc. (NASDAQ:MGRX) gained 28.8% to $0.6640 in pre-market trading. MangoRx shares jumped 104% on Tuesday after the company announced the development of oral formulations of Semaglutide and Tirzepatide.
LM Funding America, Inc. (NASDAQ:LMFA) shares climbed 20.5% to $3.95 in pre-market trading after jumping around 15% on Tuesday. LM Funding America, last week, posted better-than-expected first-quarter earnings.
VS Media Holdings Ltd (NASDAQ:VSME) gained 18.7% to $0.45 in pre-market trading after falling over 7% on Tuesday.

Losers

Crown ElectroKinetics Corp. (NASDAQ:CRKN) shares declined 27.5% to $0.0912 in pre-market trading after dipping over 36% on Tuesday. Crown ElectroKinetics, on Monday, reported a first-quarter loss of 13 cents per share.
Edible Garden AG Incorporated (NASDAQ:EDBL) shares dipped 24.7% to $3.26 in pre-market trading after gaining 14% on Tuesday. The company, last week, reported first-quarter financial results.
Sintx Technologies, Inc. (NASDAQ:SINT) shares declined 18.7% to $0.0741 in pre-market trading after dipping 19% on Tuesday.
FLJ Group Limited (NASDAQ:FLJ) shares fell 18.4% to $0.9301 in pre-market trading after jumping over 46% on Tuesday.
Chijet Motor Company, Inc. (NASDAQ:CJET) shares fell 14.6% to $0.4354 in pre-market trading after jumping 47% on Tuesday.
LifeStance Health Group, Inc. (NASDAQ:LFST) shares declined 14.4% to $6.40 in pre-market trading. LifeStance Health Group priced its secondary public offering of 20 million common shares at $6.25 per share.
Borealis Foods Inc. (NASDAQ:BRLS) shares fell 13.4% to $6.16 in pre-market trading after climbing around 78% on Tuesday.
Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) shares fell 12.2% to $0.65 in pre-market trading. Virpax Pharmaceuticals recently announced the pricing of a $2.25 million public offering.
Viasat Inc (NASDAQ:VSAT) fell 11.6% to $16.65 in pre-market trading after the company reported its fourth-quarter financial results.
Xylo Technologies Ltd. (NASDAQ:XYLO) shares fell 9.6% to $2.07 in pre-market trading. Xylo Technologies shares jumped over 16% on Tuesday after the company announced it signed a letter of intent for the strategic acquisition of a German AI tech company.